Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04177082 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Keratoconus
Pellucid Marginal Corneal Degeneration
Corneal Degeneration
Corneal Ectasia

Interventions

COMBINATION_PRODUCT: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

Sponsor

Cornea Associates of Texas